HIMS stock could 10x after being down 80%Hims & Hers Health, Inc. Class ABATS:HIMSValuePigHIMS is down 80%, creating a window of opportunity in the stock price for those interested in the business behind the chart. : "Hims & Hers (HIMS) trades around $15–16 (as of March 3, 2026), down ~75–80% from its 2025 peak of $70.43. Bullish highlights despite the dip: 2025 results: Revenue hit $2.35 billion (+59% YoY), with >2.5 million subscribers. Achieved profitability and strong cash flow from core areas (hair, ED, skin, mental health, hormones); non-GLP-1 revenue dominates in the U.S. 2026 guidance: Revenue $2.7–2.9 billion (+15–23% YoY), Adjusted EBITDA $300–375 million (11–13% margin). 2030 targets: At least $6.5 billion revenue and $1.3 billion Adjusted EBITDA — implying 20–25%+ CAGR over the coming years, fueled by new specialties (testosterone, menopause, labs), international expansion (e.g., Eucalyptus deal targeting $1B+ abroad), and personalized telehealth growth. Valuation: Trades at a compressed multiple relative to long-term growth; analyst targets suggest meaningful upside. GLP-1 headwinds (regulatory/competition) appear temporary, with diversification and platform strength supporting durable 20–30% growth potential through 2030. Classic "generational dip" setup for patient bulls in consumer health." HIMS meets my growth criteria, price to sales criteria, and sentiment potential for a great opportunity. The Company is profitable and cashflow positive, and is earning close to the sp500 and bonds already, potentially earning more as a business soon. Trade Idea- Im buying now for the long term, 2 to 10 years. If stocks moves 3x or more, I will trim to take most my cost basis out and keep the rest for free long term 10-20 years.